Table 6. Distribution of Patients With Respect to the Treatment Received and Comparison Between the Outcomes of the Different Treatment Modalities for PVT Used in This Study.
| Heparin alone (N = 51) | Heparin/warfarin (N = 99) | Rivaroxaban (N = 40) | P value | |
|---|---|---|---|---|
| Distributions | ||||
| Non-malignant-non-cirrhotic (N = 128) | 15 (11.7%) | 84 (65.6%) | 29 (22.7%) | |
| Non-malignant-cirrhotic (N = 28) | 2 (7.1%) | 15 (53.6%) | 11 (39.3%) | |
| Malignant-cirrhotic (N = 10) | 10 (100%) | 0 | 0 | |
| Malignant-non-cirrhotic (N = 24) | 24 (100%) | 0 | 0 | |
| Outcomes | ||||
| Complete recanalization | 22 (43.2%) | 49 (49.5%) | 19 (47.5%) | 0.469 |
| Partial recanalization | 8 (15.7%) | 12 (12.1%) | 5 (12.5%) | 0.821 |
| No recanalization | 14 (27.5%) | 10 (10.1%) | 3 (7.5%) | |
| No follow-up | 7 (13.7%) | 28 (28.2%) | 13 (32.5%) | |
| Mortality | 7 (13.7%) | 20 (20.2%) | 1 (2.5%) | 0.027 |
PVT: portal vein thrombosis.